3-Amino-4-Bromo-6-Chloropyridazine CAS#446273-59-2 Product Description
3-Amino-4-bromo-6-chloropyridazine (CAS No. 446273-59-2) is a nitrogen-containing heterocyclic aromatic compound with the molecular formula C₄H₃BrClN₃ and a molecular weight of 208.44 g/mol. Featuring a pyridazine ring substituted with amino, bromo, and chloro functional groups, this compound serves as a versatile building block in medicinal chemistry and pharmaceutical research. It is particularly valuable as a key synthetic intermediate in the development and preparation of novel phosphodiesterase 10A (PDE10A) inhibitors, as well as other biologically active compounds and pharmaceutical-related molecules.

3-Amino-4-Bromo-6-Chloropyridazine CAS#446273-59-2 Product Description
| Boiling point | 385.4±37.0 °C(Predicted) |
| density | 1.960 |
| storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C |
| pka | 1.93±0.10(Predicted) |
| form | powder |
3-Amino-4-Bromo-6-Chloropyridazine CAS#446273-59-2 Safety Information
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN2811 |
| HS Code | 2933998090 |
3-Amino-4-Bromo-6-Chloropyridazine CAS#446273-59-2 Product Application
This compound is primarily intended for use in chemical research and pharmaceutical development, where it serves as a valuable synthetic building block for the preparation of biologically active molecules. It is particularly relevant to the synthesis and structural optimization of imidazo[1,2-b]pyridazine derivatives, including potential phosphodiesterase 10A (PDE10A) inhibitors. Its application in medicinal chemistry supports the development and investigation of novel heterocyclic compounds with potential therapeutic properties.
![This compound is primarily intended for use in chemical research and pharmaceutical development, where it serves as a valuable synthetic building block for the preparation of biologically active molecules. It is particularly relevant to the synthesis and structural optimization of imidazo\[1,2-b\]pyridazine derivatives, including potential phosphodiesterase 10A (PDE10A) inhibitors. Its application in medicinal chemistry supports the development and investigation of novel heterocyclic compounds with potential therapeutic properties.](https://yinghaoguoji.cdn.aihuazhi.cn/image_5a746a1616.webp)